CIK 0001034842
- Accelerated filer
RIGEL PHARMACEUTICALS INC
Sign in to watch- Ticker
- RIGL
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 943248524
- Phone
- +1 650-624-1100
- Business address
- 611 GATEWAY BOULEVARD, SUITE 900, SOUTH SAN FRANCISCO, CA, 94080
- Former names
- RIGEL PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2018-05-09 | Lasaga Joseph VP Bus. Dev.& Alliance Mgmt. | Grant or award · Employee Stock Option (Right to Buy) | +25,000 | 25,000 | ||
| 2018-05-09 | Masuda Esteban Sr. VP Research | Grant or award · Employee Stock Option (Right to Buy) | +50,000 | 50,000 | ||
| 2018-05-09 | Mayer Eldon C. III EVP & Chief Commercial Officer | Grant or award · Employee Stock Option (Right to Buy) | +50,000 | 50,000 | ||
| 2018-05-09 | VANCE DOLLY EVP Corp. Affairs, G.C., Sect. | Grant or award · Employee Stock Option (Right to Buy) | +150,000 | 150,000 | ||
| 2018-05-09 | Duliege Anne-Marie EVP & Chief Medical Officer | Grant or award · Employee Stock Option (Right to Buy) | +150,000 | 150,000 | ||
| 2018-05-09 | RODRIGUEZ RAUL R CEO, President | Grant or award · Employee Stock Option (Right to Buy) | +450,000 | 450,000 | ||
| 2018-04-20 | Duliege Anne-Marie EVP & Chief Medical Officer | Sale | −5,000 | $4.11 | $21K | 0 |
| 2018-03-21 | Markel Stacy EVP Human Resources | Grant or award · Employee Stock Option (Right to Buy) | +125,000 | 125,000 | ||
| 2018-01-24 | Cabatuan Nelson Principal Accounting Officer | Grant or award · Employee Stock Option (right to buy) | +24,000 | 24,000 | ||
| 2018-01-24 | Lasaga Joseph VP Bus. Dev.& Alliance Mgmt. | Grant or award · Employee Stock Option (right to buy) | +87,500 | 87,500 | ||
| 2018-01-24 | Masuda Esteban Sr. VP Research | Grant or award · Employee Stock Option (right to buy) | +125,000 | 125,000 | ||
| 2018-01-24 | Mayer Eldon C. III EVP & Chief Commercial Officer | Grant or award · Employee Stock Option (right to buy) | +150,000 | 150,000 | ||
| 2018-01-24 | Duliege Anne-Marie Chief Medical Officer | Grant or award · Employee Stock Option (right to buy) | +150,000 | 150,000 | ||
| 2018-01-24 | VANCE DOLLY EVP Corp. Affairs, G.C., Sect. | Grant or award · Employee Stock Option (right to buy) | +150,000 | 150,000 | ||
| 2018-01-24 | RODRIGUEZ RAUL R CEO, President | Grant or award · Employee Stock Option (right to buy) | +475,000 | 475,000 | ||
| 2017-11-03 | Maynard Ryan D EVP & CFO | Exercise or conversion | +100,000 | $2.14 | $214K | 100,000 |
| 2017-11-03 | Maynard Ryan D EVP & CFO | Sale | −100,000 | $3.90 | $390K | 0 |
| 2017-11-03 | Maynard Ryan D EVP & CFO | Exercise or conversion · Employee Stock Option (right to buy) | −100,000 | 75,000 | ||
| 2017-10-31 | LAPOINTE ANTHONY GREGG Director | Grant or award · Stock Option (Right to Buy) | +80,000 | 80,000 | ||
| 2017-08-21 | Kotzin Brian L. Director | Grant or award · Stock Option (Right to Buy) | +80,000 | 80,000 |
Page 17 of 22 · 423 trades